Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 1870Neoplasms 1254Colorectal Neoplasms 1057Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 801Carcinoma, Hepatocellular 784Lung Neoplasms 768Prostatic Neoplasms 697Pancreatic Neoplasms 578Rectal Neoplasms 447Ovarian Neoplasms 406Colonic Neoplasms 405Uterine Cervical Neoplasms 400Neoplasm Metastasis 400Recurrence 380Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 339Lymphoma 335Head and Neck Neoplasms 329Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 263Urinary Bladder Neoplasms 254Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 215Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 204

Interventions

camrelizumab 1Radiotherapy 1Paclitaxel 1Injections 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Chemotherapy × Clear all
NCT05821452 2023-04-20

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Fujian Medical University Union Hospital

Phase 2 Unknown
40 enrolled

Chemotherapy

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Unknown
30 enrolled

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡